NeuBase Therapeutics, Inc.

  • ABOUT US
  • TECHNOLOGY
  • PIPELINE
  • PATIENTS
  • PARTNERING
  • INVESTORS
  • CONTACT US

In The News

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • In The News
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • In The News
  • IR Calendar
  • Email Alerts
December 13, 2021

NeuBase Therapeutics Named PM360 2021 Innovative Startup

November 17, 2021

Neuro Drug Discovery Innovations: From Maps to Drugs

September 21, 2021

Pittsburgh-based biotech company on a growth path

February 4, 2021

NeuBase has deal to buy gene modulating technology from SF startup

January 28, 2021

4 New Life Sciences Licensing Deals and Investments to Watch

December 17, 2020

7 Biopharma CEOs On Who And What To Pay Attention To In 2021 And Beyond

October 13, 2020

NeuBase Therapeutics Signs Headquarters Deal at New Riviera Project in Pittsburgh

September 8, 2020

Gene Therapy Development Crosses A Digital Divide

August 1, 2019

NeuBase takes antisense oligos to more targets in more places

July 27, 2019

Carnegie Mellon University Is a Big Backer of This Biotech Stock

rss_feed RSS
  • 1
  • 2
  • 3
  • arrow_forward
  • Email Alerts
  • Contacts
  • RSS News Feed
Neubase

NeuBase Therapeutics, Inc.
350 Technology Drive
Pittsburgh, PA 15219

info@neubasetherapeutics.com

Sign up for news

©2023 NeuBase Therapeutics, Inc. All rights reserved.

Privacy Policy|Terms of Use